Diabetic Nephropathy
📧 Sign up to get email alerts when something new happens for Diabetic Nephropathy.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-04-23FDA Approved: IRBESARTAN — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for Irbesartan (ANDA).
-
CLINICAL_TRIALS trial_result · 2019-03-12Clinical Trial Update: A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy [Phase 2]
A Phase 2, placebo-controlled trial evaluating PF-00489791 in patients with type 2 diabetes and overt nephropathy has been completed with re…
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: Study of FibroGen (FG)-3019 in Subjects With Type 2 Diabetes Mellitus and Kidney Disease on ACEi and/or ARB Therapy [Phase 2]
A Phase 2 study of pamrevlumab (FG-3019) in subjects with type 2 diabetes mellitus and diabetic kidney disease on ACE inhibitors or ARBs has…
-
CLINICAL_TRIALS trial_result · 2019-02-20Clinical Trial Update: Green Tea Extract on Soluble RAGE in Patients With Diabetic Nephropathy [Phase 2]
A Phase 2 clinical trial is evaluating the effect of green tea extract on soluble RAGE in patients with diabetic nephropathy. The current st…
-
CLINICAL_TRIALS withdrawal · 2019-02-15Clinical Trial Update: Blood/Urine Markers for Drug Discovery for Renal Disease in Diabetes
A clinical trial investigating blood and urine markers for drug discovery in diabetic kidney disease was withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-02-07Clinical Trial Update: Pentoxifylline Effect in Patients With Diabetic Nephropathy.(PENFOSIDINE STUDY) [Phase 4]
Phase 4 trial PENFOSIDINE is evaluating pentoxifylline in patients with diabetic nephropathy and chronic kidney disease stage 3-4; the curre…
-
CLINICAL_TRIALS trial_result · 2019-01-31Clinical Trial Update: Low-dose Colchicine in Patients With Type 2 Diabetes Mellitus and Microalbuminuria [NA]
Clinical trial update on low-dose colchicine in patients with Type 2 diabetes mellitus and microalbuminuria. The current status of the trial…
-
CLINICAL_TRIALS research · 2019-01-29Clinical Trial Update: Markers of Vascular Calcification in Diabetic Nephropathy in Patients With Diabetic Nephropathy
A clinical trial update examining markers of vascular calcification in patients with diabetic nephropathy. The status is UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2018-12-21Clinical Trial Update: Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria [Phase 2, Phase 3]
Phase 2/3 trial evaluating proteomic prediction and renin-angiotension-aldosterone system inhibition to prevent early diabetic nephropathy i…
-
CLINICAL_TRIALS trial_result · 2018-12-21Clinical Trial Update: A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Type 2 Diabetic Subjects With Microalbuminuria [Phase 2]
Phase 2 trial assessing efficacy and safety of CS-3150 in Japanese type 2 diabetes patients with microalbuminuria has been completed.
-
CLINICAL_TRIALS trial_result · 2018-11-20Clinical Trial Update: Effect of Urinary Alkalinization on Urine Uric Acid Precipitation and Crystallization in Adults With Type 1 Diabetes [Phase 4]
Phase 4 clinical trial assessing whether urinary alkalinization affects urine uric acid precipitation and crystallization in adults with typ…
-
CLINICAL_TRIALS trial_result · 2018-11-15Clinical Trial Update: Rhubarb and Angiotensin Converting Enzyme Inhibitor [Phase 2]
Phase 2 trial update on rhubarb in combination with an ACE inhibitor for diabetic kidney disease; study terminated with results posted in 20…
-
FDA approval · 2018-11-02FDA Approved: IRBESARTAN — Supplemental Application (Hisun Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for IRBESARTAN by Hisun Pharmaceuticals USA Inc. The approval indicates changes related to the a…
-
FDA approval · 2018-10-24FDA Approved: IRBESARTAN — Supplemental Application (NorthStar RxLLC)
The FDA approved a supplemental application for IRBESARTAN (irbesartan) submitted by NorthStar RxLLC.
-
FDA approval · 2018-10-12FDA Approved: COZAAR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Cozaar (losartan potassium) from Organon LLC.
-
CLINICAL_TRIALS withdrawal · 2018-09-14Clinical Trial Update: Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation (ROTATE-2) [Phase 4]
A Phase 4 trial ROTATE-2 investigating albuminuria targeting in diabetic nephropathy was withdrawn.
-
CLINICAL_TRIALS trial_result · 2018-09-10Clinical Trial Update: Microalbuminuria and Allopurinol in Type 1 Diabetes [Phase 4]
A Phase 4 clinical trial update evaluating the effect of allopurinol on microalbuminuria in individuals with Type 1 diabetes and diabetic ne…
-
CLINICAL_TRIALS trial_result · 2018-09-10Clinical Trial Update: Effects of Dapagliflozin Treatment on Urinary Proteomic Patterns in Patients With Type 2 Diabetes [Phase 4]
Phase 4 clinical trial exploring how dapagliflozin affects urinary proteomic patterns in patients with type 2 diabetes and diabetic nephropa…
-
CLINICAL_TRIALS trial_result · 2018-09-06Clinical Trial Update: An Intervention to Examine the Effect of Vitamin D on Urine Protein Levels in Type 2 Diabetes [Phase 3]
Phase 3 clinical trial investigating the effect of Vitamin D on urine protein levels in adults with type 2 diabetes and diabetic nephropathy…
-
CLINICAL_TRIALS trial_result · 2018-08-13Clinical Trial Update: A Phase 2 Dose-finding Study of TAK-272 in Participants With Type 2 Diabetes Mellitus and Microalbuminuria [Phase 2]
Phase 2 dose-finding study of TAK-272 in participants with type 2 diabetes mellitus and microalbuminuria completed; results posted in 2018.
-
FDA approval · 2018-08-01FDA Approved: ENALAPRIL MALEATE — Supplemental Application (OCEANSIDE PHARMACEUTICALS)
FDA approved a supplemental application for enalapril maleate from Oceanside Pharmaceuticals, indicating an updated/expanded labeling for th…
-
FDA approval · 2018-07-20FDA Approved: AVAPRO — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for AVAPRO (irbesartan) submitted by Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS trial_result · 2018-07-20Clinical Trial Update: Vitamin B Complex and Diabetic Nephropathy in Type 1 Diabetes [Phase 3]
A Phase 3 trial evaluating Vitamin B Complex in adults with type 1 diabetes and diabetic nephropathy has completed, with data collected on p…
-
CLINICAL_TRIALS research · 2018-07-19Clinical Trial Update: T-regulatory Cells in Diabetic Type Two Nephropathy
This entry reports an ongoing clinical trial investigating regulatory T cells as a treatment for diabetic nephropathy in type 2 diabetes, wi…
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: A Study of Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) for the Treatment of Chronic Renal Anemia in Participants With Diabetic Nephropathy [Phase 4]
A Phase 4 study evaluating Mircera for chronic renal anemia in patients with diabetic nephropathy has completed.